Cargando…
Metabolism Study of Anamorelin, a GHSR1a Receptor Agonist Potentially Misused in Sport, with Human Hepatocytes and LC-HRMS/MS
Anamorelin, developed for the treatment of cancer cachexia, is an orally active medication that improves appetite and food intake, thereby increasing body mass and physical functioning. It is classified as a growth hormone secretagogue and strictly monitored by the World Anti-Doping Agency (WADA), o...
Autores principales: | Gameli, Prince Sellase, Taoussi, Omayema, Basile, Giuseppe, Carlier, Jeremy, Busardò, Francesco Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10456928/ https://www.ncbi.nlm.nih.gov/pubmed/37623892 http://dx.doi.org/10.3390/metabo13080949 |
Ejemplares similares
-
Oncology Update: Anamorelin
por: Prommer, Eric
Publicado: (2017) -
Untargeted Metabolic Profiling of 4-Fluoro-Furanylfentanyl and Isobutyrylfentanyl in Mouse Hepatocytes and Urine by Means of LC-HRMS
por: Montesano, Camilla, et al.
Publicado: (2021) -
Assessing the Effectiveness of Chemical Marker Extraction from Amazonian Plant Cupuassu (Theobroma grandiflorum) by PSI-HRMS/MS and LC-HRMS/MS
por: Lima, Nerilson M., et al.
Publicado: (2023) -
Investigation of Bemethyl Biotransformation Pathways by Combination of LC–MS/HRMS and In Silico Methods
por: Belinskaia, Daria A., et al.
Publicado: (2021) -
Determination of hair cortisol in horses: comparison of immunoassay vs LC-HRMS/MS
por: Saluti, Giorgio, et al.
Publicado: (2022)